These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Various pharmacological approaches to normalization of lipid metabolism in patients with arteriosclerosis]. Klimov AN; Nikulchev NG Ter Arkh; 1973; 45(6):29-33. PubMed ID: 4127839 [No Abstract] [Full Text] [Related]
43. [Study of pyridinolcarbamate in the treatment of diabetic angiopathies and atheromatous arteritis]. Plauchu M; Bussy L; Rondelet J Lyon Med; 1972 Feb; 227(3):271-7. PubMed ID: 5037162 [No Abstract] [Full Text] [Related]
44. [Clinical experiences with pyridinolcarbamate in ophthalmology]. Musini A; Fabbri G; Tancini G Ann Ottalmol Clin Ocul; 1969 Feb; 95(2):101-23. PubMed ID: 5398786 [No Abstract] [Full Text] [Related]
45. [Some aggregation parameters in the bulbar vessels used for assessing the clinical course of retinopathy in patients with essential hypertension and diabetes mellitus]. Smirennaia EV; Polunin GS; Pirogova EP; Vorobéva OK; Makarov IA Vestn Oftalmol; 1996; 112(3):28-30. PubMed ID: 8966860 [TBL] [Abstract][Full Text] [Related]
46. Clinical applications of anginin in ophthalmology. I. A case of the arteriosclerotic retinopathy with the retinal venous thrombosis favorably treated with anginin, especially effects of anginin on white sheating of the retinal artery. Matsuo N; Matsuo H; Hasegawa E; Obuchi Y Acta Med Okayama (1952); 1967 Apr; 21(2):59-66. PubMed ID: 4229454 [No Abstract] [Full Text] [Related]
47. [Vascular obturation in diabetic retinopathy using 0-beta-hydroxyethyl-rutoside]. Freyler H; Haydn M Klin Monbl Augenheilkd; 1972 May; 160(5):527-33. PubMed ID: 5075949 [No Abstract] [Full Text] [Related]
48. [Changes in the system of blood coagulation under the influence of a series of therapeutic measures]. Sarkisian TG Zh Eksp Klin Med; 1969; 9(4):69-73. PubMed ID: 4193492 [No Abstract] [Full Text] [Related]
49. [Decrease of vascular fragility in diabetic retinopathy through calciumdobesilate (author's transl)]. Freyler H; Sehorst W Klin Monbl Augenheilkd; 1974 Feb; 164(2):246-51. PubMed ID: 4842139 [No Abstract] [Full Text] [Related]
50. Photocoagulation and local steroid-induced ocular hypertension in the treatment of diabetic retinopathy. Gills JP; Anderson WB Arch Intern Med; 1969 Jun; 123(6):626-31. PubMed ID: 5771051 [No Abstract] [Full Text] [Related]
51. [Action of synthetic derivatives of Congo red. Angiographic study]. Zenatti C Ann Ocul (Paris); 1971 Mar; 204(3):257-70. PubMed ID: 5089202 [No Abstract] [Full Text] [Related]
52. [Selected problems of conservative treatment of retinal diseases]. Kozuchowska I Klin Oczna; 1973 Feb; 43(2):135-40. PubMed ID: 4805030 [No Abstract] [Full Text] [Related]
53. Arteriosclerotic macular degeneration; effect of lipotropic substances (lipotriad) in treatment. HILGARTNER HL Tex State J Med; 1955 Nov; 51(11):733-4. PubMed ID: 13274348 [No Abstract] [Full Text] [Related]
54. [Therapeutic studies with anthocyanins in long term therapy in ophthalmology]. Neumann L Klin Monbl Augenheilkd; 1971 Apr; 158(4):592-7. PubMed ID: 4996166 [No Abstract] [Full Text] [Related]
55. Influence of flickering light on the retinal vessels in diabetic patients. Mandecka A; Dawczynski J; Blum M; Müller N; Kloos C; Wolf G; Vilser W; Hoyer H; Müller UA Diabetes Care; 2007 Dec; 30(12):3048-52. PubMed ID: 17728481 [TBL] [Abstract][Full Text] [Related]
56. [Therapeutic use of phosphatides in retinal diseases. Preliminary communication on the behaviour of visual acuity in macular disease and retinitis pigmentosa]. Weiss H; Kosmath B Klin Monbl Augenheilkd; 1971 Feb; 158(2):278-85. PubMed ID: 5555605 [No Abstract] [Full Text] [Related]